rs6026579

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_080425.4(GNAS):​c.2069-6674C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000024 in 125,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

GNAS
NM_080425.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.21

Publications

8 publications found
Variant links:
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS Gene-Disease associations (from GenCC):
  • McCune-Albright syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • progressive osseous heteroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohypoparathyroidism type 1B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudohypoparathyroidism type 1C
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudopseudohypoparathyroidism
    Inheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • pseudohypoparathyroidism type 1A
    Inheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_080425.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNAS
NM_080425.4
MANE Plus Clinical
c.2069-6674C>A
intron
N/ANP_536350.2
GNAS
NM_016592.5
MANE Plus Clinical
c.*43-6674C>A
intron
N/ANP_057676.1
GNAS
NM_001410913.1
c.2069-6674C>A
intron
N/ANP_001397842.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNAS
ENST00000371100.9
TSL:5 MANE Plus Clinical
c.2069-6674C>A
intron
N/AENSP00000360141.3
GNAS
ENST00000371075.7
TSL:1 MANE Plus Clinical
c.*43-6674C>A
intron
N/AENSP00000360115.3
GNAS
ENST00000676826.2
c.2069-6674C>A
intron
N/AENSP00000504675.2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.0000240
AC:
3
AN:
125250
Hom.:
0
Cov.:
4
AF XY:
0.0000336
AC XY:
2
AN XY:
59490
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2350
American (AMR)
AF:
0.00
AC:
0
AN:
154
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
746
East Asian (EAS)
AF:
0.00
AC:
0
AN:
536
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2488
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
248
European-Non Finnish (NFE)
AF:
0.0000262
AC:
3
AN:
114534
Other (OTH)
AF:
0.00
AC:
0
AN:
4154
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
10486

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
6.9
DANN
Benign
0.93
PhyloP100
-1.2
PromoterAI
-0.032
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6026579; hg19: chr20-57463993; API